Drug
Indacaterol clinical trials
Also written QAB149 and Onbrez.
Includes 14 studies of Indacaterol maleate, 5 studies of Indacaterol acetate and 1 study of Indacaterol fumarate.
- studies test it
- 84
- open now
- 1
- in phase 3
- 32
- first study started
- 2004
Keep track of what changes. Save the indacaterol studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
Development codes
Combined with it in one product
Studies by the year they started
84 studies that test it; most in 2008 (11)
| Year | Studies |
|---|---|
| 2004 | 2 |
| 2006 | 8 |
| 2007 | 10 |
| 2008 | 11 |
| 2009 | 10 |
| 2010 | 6 |
| 2011 | 5 |
| 2012 | 5 |
| 2013 | 8 |
| 2014 | 4 |
| 2015 | 4 |
| 2016 | 4 |
| 2017 | 4 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 6
- Phase 2
- 27
- Phase 3
- 32
- Phase 4
- 22
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
- Asthma
- 20
Who runs them
Industry 69 · Other 15
Novartis Pharmaceuticals (43) · Novartis (24) · University of Milan (3) · National Institute of Respiratory Diseases, Mexico (2) · University of Michigan (1) · Orion Corporation, Orion Pharma (1) · Centre Hospitalier Universitaire de Besancon (1) · Centro Cardiologico Monzino (1)
Often tested with
Tested in the same studies.
Glycopyrrolate (11) · Tiotropium (7) · Mometasone Furoate (6) · Salmeterol Xinafoate (4) · Vilanterol (2) · Budesonide (1) · Fluticasone (1) · Albuterol (1)
Studies
Open first, then newest update. How each study uses indacaterol is read from its arms, and is right about nine times in ten.
Testing it · 84
- Role of Lung Function for Exercise Capacity in Well-trained IndividualsRecruitingNot applicableMorten Hostrup, PhDNCT06077019Written as Indacaterol and Mometasone Furoate
- Comparative Efficacy of Once-daily LAMA/LABA Combinations Versus Tiotropium on Constant-work-rate Cycle Endurance in COPDSuspendedNot applicableMedical University of BialystokNCT07541378Written as Indacaterol
- Study of QMF149 (150/80 µg) Compared With MF Twisthaler® (200 µg) in Patients With AsthmaCompletedPhase 3Novartis PharmaceuticalsNCT02892344Written as QMF149 150/80 μg
- Efficacy and Safety of Indacaterol vs Tiotropium in Women With COPD Secondary to Biomass ExposureCompletedPhase 4National Institute of Respiratory Diseases, MexicoNCT05506865Written as Indacaterol
- RETHINC: REdefining THerapy In Early COPD for the Pulmonary Trials CooperativeCompletedPhase 3University of MichiganNCT02867761Written as Indacaterol/Glycopyrrolate
- Study to Compare Relative Bioavailability of 3 Indacaterol/Glycopyrronium Test Products and Reference ProductCompletedPhase 1Orion Corporation, Orion PharmaNCT05288075Written as Indacaterol/glycopyrronium
- Effects of Long Acting Bronchodilators on CARDiac Autonomic Control in Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 4Centre Hospitalier Universitaire de BesanconNCT02872090Written as Indacaterol
- Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.CompletedPhase 2Novartis PharmaceuticalsNCT03257995Written as Indacaterol maleate
- Tolerability of Indacaterol Salts (Maleate, Xinafoate and Acetate) in Comparison to Placebo in Patients With Mild to Moderate Persistent AsthmaCompletedPhase 1NovartisNCT00624702Written as Indacaterol maleate
- A Multicenter Randomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Participants With AsthmaCompletedPhase 3Novartis PharmaceuticalsNCT02554786Written as Indacaterol acetate/Mometasone furoate
- Efficacy and Safety of Indacaterol Acetate Delivered Via the Concept1 Inhalation Device in Children Greater or Equal to 6 and Less Than 12 Years of Age With AsthmaCompletedPhase 2Novartis PharmaceuticalsNCT02892019Written as Indacaterol acetate 75 μg
- Indacaterol in Heart Failure Patients: Any Role on Lung Fluid RegulationCompletedPhase 3Centro Cardiologico MonzinoNCT02598505Written as Indacaterol
- A 1-year Multi-center, Prospective, Cohort Study in Patients With Chronic Obstructive Pulmonary Disease Treated With Long-acting BronchodilatorCompletedPhase 4Novartis PharmaceuticalsNCT01794780Written as LABA based treatment: indacaterol
- Prospective Cohort Study for the Real - Life Effectiveness Evaluation of GlycOpyrronium With IndacatERol Combination in the Management of COPD in Canada (POWER Study)CompletedPhase 4Novartis PharmaceuticalsNCT02202616Written as Glycopyrronium /Indacaterol maleate
- Ultra-long Acting Bronchodilator Therapy in AsthmaticsCompletedPhase 4University of DundeeNCT02039011Written as Indacaterol
- Study to Evaluate the Efficacy and Safety of Glycopyrronium or Indacaterol Maleate and Glycopyrronium Bromide Fixed-dose Combination Regarding Symptoms and Health Status in Patients With Moderate COPD Switching From Treatment With Any Standard COPD RegimenCompletedPhase 4Novartis PharmaceuticalsNCT01985334Written as Indacaterol maleate and glycopyrronium bromide
- Efficacy and Safety of QVA149 in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 2Novartis PharmaceuticalsNCT00570778Written as indacaterol/glycopyrrolate
- Utilizing Wearable Device to Observe the Clinical Response of COPD Patients Treated With Combined Bronchodilator and Home-based Pulmonary Rehabilitation ProgramStatus unknownPhase 4Taipei Medical University Shuang Ho HospitalNCT03364829Written as Indacaterol/Glycopyrronium
- Effects of Indacaterol in Symptomatic COPD Patients With Low Risk of ExacerbationsCompletedPhase 4Novartis PharmaceuticalsNCT02418468Written as Indacaterol
- Effect of a LAMA and a uLABA on the Methacholine Dose-response CurveCompletedPhase 4University of SaskatchewanNCT02953041Written as Indacaterol
See all 84 studies that test indacaterol →
Given in every arm · 4 — indacaterol is usual care beside what is tested
- Absorption of Indacaterol and Glycopyrronium From Ultibro BreezhalerCompletedPhase 1Orion Corporation, Orion PharmaNCT04856098Written as Indacaterol maleate and glycopyrronium bromide
- Swiss studY for the Treatment of COPD Patients With the Free combiNation of indacatERol and GlYcopyrroniumbromide.CompletedPhase 3Novartis PharmaceuticalsNCT01699685Written as QAB149
- Study of Indacaterol Dosed in the Evening in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 3NovartisNCT00615030Written as Indacaterol
- A Crossover Study to Determine the Effect on Lung Function of Indacaterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD), Using Tiotropium as an Active ControlCompletedPhase 3NovartisNCT00615459Written as Indacaterol
As the comparator · 8 — what is tested is compared with indacaterol
- ANTES B+ Clinical TrialTerminatedPhase 4Fundacio Privada Mon Clinic BarcelonaNCT06282861Written as Onbrez
- Two-part Pharmacokinetic and Pharmacodynamic Study of LAS190792 in Patients With Asthma and COPDCompletedPhase 1AstraZenecaNCT02059434Written as Indacaterol 150 μg
- A Multi-centre Randomized Double Blind 52-week Study to Assess the Safety of QVA149 Compared to QAB149 in Patients With COPD Who Have Moderate to Severe Airflow LimitationCompletedPhase 3Novartis PharmaceuticalsNCT01682863Written as QAB149
- A 12 Week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation.CompletedPhase 3Novartis PharmaceuticalsNCT01727141Written as QAB149
- A 12-week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow LimitationCompletedPhase 3Novartis PharmaceuticalsNCT01712516Written as QAB149
- Comparison of Safety and Efficacy of the Combination Product QVA149A Against the Concurrent Administration of the Individual Components, QAB149 and NVA237, in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 3Novartis PharmaceuticalsNCT01529632Written as QAB149
- A Study to Assess the Efficacy, Safety and Tolerability of Once-daily (q.d.) QVA149 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedPhase 3Novartis PharmaceuticalsNCT01202188Written as indacaterol (QAB149)
- A Single-dose Study to Investigate the Effects of 3 Different Doses of Inhaled AZD2115 in COPD PatientsCompletedPhase 2AstraZenecaNCT01498081Written as Indacaterol
Codes
What other systems call indacaterol · ClinicalTrials.gg INT004916
- MeSH (NLM) C510790indacaterolConfirmed NLM, Wikidata
- UNII (FDA) 8OR09251MQINDACATEROLConfirmed FDA, NLM, Wikidata
- RxNorm 1114326Confirmed FDA, Wikidata
- Wikidata Q425654indacaterolConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C81644IndacaterolOne source FDA
- DrugBank DB05039One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C510790 | indacaterol | Confirmed NLM, Wikidata |
| UNII (FDA) | 8OR09251MQ | INDACATEROL | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1114326 | — | Confirmed FDA, Wikidata |
| Wikidata | Q425654 | indacaterol | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C81644 | Indacaterol | One source FDA |
| DrugBank | DB05039 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.